| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |